There is an increasing trend towards evaluating the prognostic role of novel, readily available hematological pro-inflammatory markers in cardiac patients given the involved cost limits the routine performance of established markers of inflammation, such as high sensitivity-complement reactive protein and procalcitonin.
← all excerpts
Retrospective Evaluation of Platelet-Leukocyte Indices and Cardiac Surgical Outcomes in Acyanotic Heart Disease Patients with Pulmonary Hypertension (REPLICA-PH).
1
—
—